Beyfortus (nirsevimab) Now Available Through VFC

• 2024

  Sign in to bookmark this resource.

  Sign in

---

Access Resources

• Job AidEN

About

This announcement explains that providers can order nirsevimab (Beyfortus) through Vaccines for Children (VFC). It covers the following areas of consideration: dosage and administration, eligible patients, dosage reporting, storage and handling, and adverse events reporting.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Nirsevimab Library

Keywords: Cystic Fibrosis; Infant; Lung Diseases; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Immunocompromised Host; Adverse Drug Reaction Reporting Systems; Immunization Programs; Vaccines, Combined; Antibodies, Monoclonal, Humanized

Institutions: Philadelphia Department of Public Health

---

More like this

Reporting Beyfortus to the Texas Immunization Registry: Data Quality Challenges 2024 · Texas Department of State Health Services Nirsevimab (Beyfortus) Guide to Prevent Severe RSV in Infants and Toddlers 2023 · California Department of Public Health Updated Interim Guidance for Health Departments on Testing and Reporting for Oropouche Virus Disease 2024 · Centers for Disease Control and Prevention (CDC)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---